The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Harmonizing cancer care delivery for AYAs with osteosarcoma: Comparison of pediatric and medical oncology approaches in a single center.
 
Ariel Nash
No Relationships to Disclose
 
Ravin Ratan
Stock and Other Ownership Interests - Johnson & Johnson/Janssen (I); Medtronic (I)
Honoraria - Peerview; touchIME
Consulting or Advisory Role - Epizyme; InhibRx
Research Funding - Ayala Pharmaceuticals (Inst); Bayer; C4 Therapeutics (Inst); Epizyme; SpringWorks Therapeutics (Inst); SpringWorks Therapeutics (Inst)
Travel, Accommodations, Expenses - SpringWorks Therapeutics; SpringWorks Therapeutics
 
Neeta Somaiah
Stock and Other Ownership Interests - JNJ (I); Pfizer (I)
Consulting or Advisory Role - AADi; Bayer; Blueprint Medicines; Boehringer Ingelheim; Deciphera; Epizyme
Research Funding - Advenc; Ascentage Pharma; AstraZeneca/MedImmune (Inst); Cogent Biosciences; Daiichi Sankyo/Lilly; Deciphera; GlaxoSmithKline; Karyopharm Therapeutics
 
Anthony Paul Conley
Consulting or Advisory Role - AADi; Applied Clinical Intelligence; Bayer; Deciphera; Deciphera; Genentech; Guidepoint Global; Guidepoint Global; InhibRx; Medscape; Nektar; Novartis; OncLive; Schlesinger Associates
Research Funding - Bavarian Nordic (Inst); Chordoma Foundation (Inst); EpicentRx (Inst); Ignyta (Inst); InhibRx (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); MedImmune (Inst); NantHealth (Inst); NCI (Inst)
Travel, Accommodations, Expenses - Genentech
 
Valerae O. Lewis
No Relationships to Disclose
 
Wei-Lien Wang
No Relationships to Disclose
 
Heather Y. Lin
No Relationships to Disclose
 
Najat C. Daw
Patents, Royalties, Other Intellectual Property - Two Provisional Patents for radiotherapeutic microspheres were filed in 2019 and 2021 at University of Texas Health Science Center at San Antonio. (I)
 
Jonathan Benjamin Gill
Consulting or Advisory Role - Acceleron Pharma (I); Acceleron Pharma (I); Celgene (I); Grail (I); ImmunityBio (I); Legend Biotech (I); MEI Pharma (I); MEI Pharma (I)
 
Douglas James Harrison
No Relationships to Disclose
 
Richard Greg Gorlick
Consulting or Advisory Role - Abbvie; Jazz Pharmaceuticals
Research Funding - Eisai (Inst); HebeCell (Inst); Repare Therapeutics (Inst)
 
Shreyaskumar Patel
Consulting or Advisory Role - Daiichi Sankyo; Deciphera; Rain Oncology
Research Funding - PTC Therapeutics; Rain Therapeutics (Inst)
 
J. Andrew Livingston
Consulting or Advisory Role - SpringWorks Therapeutics
Research Funding - Exelixis (Inst); Genentech/Roche (Inst); Repare Therapeutics (Inst)
Other Relationship - Guidepoint Global